MooPoong (Gye Young Jeong) increases HDL-cholesterol but decreases LDL cholesterol and body-weight

Immunopharmacology and Immunotoxicology

Volumn 26, Issue 2, 2004, Pages 225-232

  Chung, Hwan Suck ^a,b   Hong, Seung Heon ^b   Do, Keum Rok ^c   Rhee, Hyung Koo ^a   Jung, Sung Ki ^a   Hwang, Woo Jun ^c   Kim, Hyung Min ^a  

^a Kyung Hee University   (South Korea)

^b Wonkwang University   (South Korea)

^c Wonkwang University   (South Korea)

Author keywords

Blood circulatory trouble; High density lipoprotein cholesterol; High fat diet; Low density lipoprotein cholesterol; MooPoong; Overweight

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER METABOLISM; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION; WINE;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FATS; KOREA; MALE; RATS; RATS, SPRAGUE-DAWLEY; WEIGHT GAIN; WINE;

ANIMALIA;

EID: 2942582208     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120037718     Document Type: Article

References (29)

1. Kang, Y.H.; Park, Y.K.; Ha, T.Y.; Moon, K.D. Effects of pine needle extracts on serum and liver lipid contents in rats fed high fat diet. J. Korean Soc. Food Nutr. 1996, 25, 367.
2. Slowing, K.; Ganado, P.; Sanz, M.; Ruiz, E.; Tejerina, T. Study of garlic extracts and fractions on cholesterol plasma levels and vascular reactivity in cholesterol-fed rats. J. Nutr. 2001, 131 (3), 994.
3. Hwang, W.J.; Park, E.J.; Jang, C.H.; Han, S.W.; Oh, G.J.; Kim, N.S.; Kim, H.M. Inhibitory effect of immunoglobulin E production by jin-deuk-chal (Siegesbeckia orientalis). Immunopharmacol. Immunotoxicol. 2001, 23 (4), 555.
4. Zhu, Y.P. Chinese Materia Medica Chemistry, Pharmacology and Applications; Harwood academic publishers: Netherlands, 1998; 264-266.
5. Su, Z.W.; Qiao, C.Z. Pharmacognosy; Shanghai Medical University Press: Shanghai, 1989; 228-230.
6. Cui, X.; Sakaguchi, T.; Ishizuka, D.; Tsukada, K.; Hatakeyama, K. Orally administered ginseng extract reduces serum total cholesterol and triglycerides that induce fatty liver in 66% hepatectomized rats. J. Int. Med. Res. 1998, 26 (4) 181.
7. Popkin, B.M.; Doak, C.M. The obesity epidemic is a worldwide phenomenon. Nutr. Rev. 1998, 56, 106.
8. Flatt, J.P. McCollum Award Lecture, 1995 Diet, lifestyle, and weight maintence. Am. J. Clin. Nutr. 1995, 62, 820.
9. Oscai, L.B.; Miller, W.C.; Amall, D.A. Effects of dietary sugar and of dietary fat on food intake and body fat content in rats. Growth 1987, 51, 64.
10. Oscai, L.B.; Brown, M.M.; Miller, W.C. Effect of dietary fat on food intake, growth and body composition in rats. Growth 1984, 48, 415.
11. Barnard, R.J.; Roberts, C.K.; Varon, S.M.; Berger, J.J. Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J. Appl. Physiol. 1998, 84, 1311.
12. Miller, W.C.; Niederpruem, M.G.; Wallace, J.P.; Lindeman, A.K. Dietary fat, sugar, and fiber predict body fat content. J. Am. Diet. Assoc. 1994, 94, 612.
13. Hill, J.O.; Prentice, A.M. Sugar and body weight regulation. Am. J. Clin. Nutr. 1995, 62, 264S-273S, discussion 273S.
14. Allain, C.C.; Poon, L.S.; Chan, C.S.G.; Richmond, W.; Fu, P.C. Enzymatic determination of total plasma cholesterol. Clin. Chem. 1974, 10, 470.
15. Badham, D.; Trinder, P. An improved color reagent for the determination of blood glucose by the oxidose system. Analyst 1972, 97, 142.
16. Pitt, B.; Mancini, G.B.J.; Ellis, S.G.; Rosman, H.S.; Park, J.S.; McGovern, M.E. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. J. Am. Coll. Cardiol. 1995, 26, 1133.
17. Friedewald, W.T.; Levy, R.I.; Fredrickson, D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499.
18. Garrow, J.S. Obesity and Related Diseases; Churchill Livingstone: London, 1988.
19. Flegal, K.M.; Carrol, M.D.; Kuczmaraki, R.J.; Johnson, C.L. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int. J. Obes. 1998, 22, 39.
20. Garrow, J.S. Treatment of obesity. Lancet 1992, 340, 409.
21. Wojcicki, J.; Samochowiec, L.; Jaworska, M.; Hinek, A. A research for a model of experimental atherosclerosis, comparative studies in rabbits, guinea pigs and rats. Pol. J. Pharmacol. Pharm. 1985, 37, 11.
22. Sacks, F.M.; Pfeffer, M.; Moye, L.A.; Rouleau, J.L.; Rutherford, J.D.; Cole, T.G.; Brown, L.; Warnica, J.W.; Arnold, J.M.; Wun, C.C.; Davis, B.R.; Braunwald, E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N. Engl. J. Med. 1996, 335, 1001.
23. Shepherd, J.; Cobbe, S.M.; Ford, I.; Isles, C.G.; Lorimer, A.R.; MacFarlane, P.W.; McKillop, J.H.; Packard, C.J.; For the West of Scotland Coronary Prevention Study Group Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med. 1995, 333, 1301.
24. Downs, J.R.; Clearfield, M.; Weis, S.; Whitney, E.; Shapiro, D.R.; Beere, P.A.; Langendorfer, A.; Stein, E.A.; Kruyer, W.; Gotto, A.M.; For the AFCAPS/TexCAPS Research Group Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA 1998, 279, 1615.
25. Gordon, T.; Castelli, W.P.; Hjortland, M.C.; Kannel, W.B.; Dawber, T.R. High density lipoprotein as a protective factor against coronary heart disease: the Framingham study. Am. J. Med. 1977, 62, 707.
26. Miller, N.E.; Forde, O.H.; Thelle, D.S.; Mjos, O.D. The Tromso Heart Study: high-density lipoprotein as a protective factor against coronary heart disease: a prospective case-control study. Lancet 1977, 1, 965.
27. Gordon, D.J.; Rifkind, B.M. High density lipoprotein: the clinical implications of recent studies. N. Engl. J. Med. 1989, 321, 1311.
28. Reichl, D.; Miller, N.E. Pathophysiology of reverse cholesterol transport. Insight from inherited disorders of lipoprotein metabolism. Arterioscler. Thromb. Vasc. 1989, 9, 785.
29. Durrington, P.N. How HDL protects against atheroma. Lancet 1993, 342, 1315.